The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

CHEMBL352949     N-(4-bromophenyl)-3-oxo-4,5- diphenyl...

Synonyms: ACMC-1C65U, AG-D-78605, SureCN8846957, CTK4C1465, KB-214417, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

High impact information on LY 262691

  • Systemic injection of CCK-8, of a selective CCK-A agonist, or of non-peptide CCK-B antagonists (CI-988 and LY-262691) enhanced olfactory recognition [1].
  • LY 288513, a selective CCKB receptor antagonist (0.01 mg/kg), prevented the increase in exploratory activity in the DSP-4-treated rats, but increased the exploratory activity of controls on the third exposure to the test situation [2].
 

Gene context of LY 262691

  • By contrast, the CCKB receptor antagnoists PD 135,158 (0.001-0.01, 1 mg/kg, i.p.) and LY 288513 (1 and 3 mg/kg, i.p.) significantly decreased avoidance distance when the rat was first placed in the test apparatus, an effect which is consistent with an anti-panic-like action [3].

References

  1. CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats. Lemaire, M., Böhme, G.A., Piot, O., Roques, B.P., Blanchard, J.C. Psychopharmacology (Berl.) (1994) [Pubmed]
  2. Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation. Harro, J., Oreland, L., Vasar, E., Bradwejn, J. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. (1995) [Pubmed]
  3. CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours. Griebel, G., Perrault, G., Sanger, D.J. Behavioural pharmacology. (1997) [Pubmed]
 
WikiGenes - Universities